Cefoxitin

FDA Approved: * July 3, 2000
Pharm Company: * AM PHARM PARTNERS
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cefoxitin Overview

Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. It was synthesized in order to create an antibiotic with a broader spectrum.[1] It is often grouped with the second-generation cephalosporins.[2] Cefoxitin requires a prescription and as of 2010 is sold under the brand name Mefoxin by Bioniche Pharma, LLC. The generic version of Mefoxin is known as cefoxitin sodi...

Read more Cefoxitin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefoxitin

Recent Cefoxitin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cefoxitin
  • Injection: 10g, 10gm/vial, 1g, 1g/50ml, 1gm/vial, 2g, 2g/50ml, 2gm/2vial + 2gm/vial, 2gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cefoxitin: (24 results)

Showing the first 20, Sorted by National Drug Code
  • 0143-9876 Cefoxitin 1 g/10ml Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0143-9877 Cefoxitin 2 g/1 Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0143-9878 Cefoxitin 1 g/1 Intravenous Injection, Powder, for Solution by West-ward Pharmaceutical Corp
  • 0264-3123 Cefoxitin and Dextrose 1 g/50ml Intravenous Injection, Solution by B. Braun Medical Inc.
  • 0264-3125 Cefoxitin and Dextrose 2 g/50ml Intravenous Injection, Solution by B. Braun Medical Inc.
  • 25021-109 Cefoxitin 1 g/1 Intravenous Powder by Sagent Pharmaceuticals
  • 25021-110 Cefoxitin 2 g/1 Intravenous Powder by Sagent Pharmaceuticals
  • 25021-111 Cefoxitin 10 g/1 Intravenous Injection by Sagent Pharmaceuticals
  • 44567-245 Cefoxitin 1 g/1 Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-246 Cefoxitin 2 g/1 Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-247 Cefoxitin 10 g/1 Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-330 Cefoxitin 1 g/10ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-331 Cefoxitin 2 g/10ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 44567-332 Cefoxitin 10 g/100ml Intravenous Injection, Powder, for Solution by Wg Critical Care, LLC
  • 60505-0759 Cefoxitin 1 g/1 Intravenous Injection, Powder, for Solution by Apotex Corporation
  • 60505-0760 Cefoxitin 2 g/1 Intravenous Injection, Powder, for Solution by Apotex Corporation
  • 60505-0761 Cefoxitin 10 g/1 Intravenous Injection, Powder, for Solution by Apotex Corporation
  • 60505-6025 Cefoxitin 1 g/1 Intravenous Injection, Powder, for Solution by Apotex Corporation
  • 60505-6026 Cefoxitin 2 g/1 Intravenous Injection, Powder, for Solution by Apotex Corporation
  • 61786-429 Cefoxitin 1 g/1 Intravenous Injection, Powder, for Solution by Remedyrepack Inc.
  • 4 more results ...

Other drugs which contain Cefoxitin or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA